Quantcast

Industry news that matters to you.  Learn more

Triple-Biomarker Approach Improves Chronic Kidney Disease Prediction Accuracy

Researchers have found that a combination biomarker approach improves risk prediction for chronic kidney disease (CKD). The study, published in the Journal of the American Medical Association (JAMA), concluded that adding cystatin C to the combination of creatinine and albumin-to-creatinine ratio (ACR) measures improved the predictive accuracy for all-cause mortality and end-stage renal disease.